Share
Tradeoffs
Race to the Bottom: Boom Times
Season 1, Ep. 286
•
Generic drugs are, in many ways, the unsung hero of America’s health care system, bringing powerful medical innovations within the reach of millions more people. These cheaper copies of brand-name drugs — from pills that stop heart attacks to antibiotics that cure life-threatening infections — save America hundreds of billions of dollars a year. But will affordable, high-quality generic drugs continue to be there when we need them?
Some players are abandoning this business while others slash costs by cutting dangerous corners. Shortages of older generic drugs have become the norm, sending doctors scrambling. At the same time, crucial new medicines are proving tougher to copy on the cheap, saddling patients with brand-name prices.
Over the course of “Race to the Bottom,” our new three-part podcast series, we’ll explore why this industry that’s so essential to our health is in trouble — and what could change that.
In part one, we examine the history of this industry. Forty years ago this month, President Ronald Reagan signed groundbreaking, bipartisan legislation that gave birth to a new drug market. Lawmakers made choices back then that help explain the wild success and also the troubles we see today with generic medicines.
Guests:
Christine Baeder, MBA, President, Apotex USA
Alfred Engelberg, JD, retired attorney and former counsel to the Generic Pharmaceutical Association
Leslie Walker, Senior Reporter/Producer, Tradeoffs
Learn more and read a full transcript on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift.
More episodes
View all episodes
300. Trump Forced Hospitals and Insurers to Reveal Their Prices. What Happened?
14:24||Season 1, Ep. 300A mandate to make health care prices public was one of President Trump’s signature health policies in his first term. But forcing hospitals to publish prices hasn’t yet helped patients shop around for medical care.Guest:Melanie Evans, Producer, TradeoffsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.299. Everyone’s Mad at Health Insurers, But 'There’s Plenty of Blame to Go Around'
22:08||Season 1, Ep. 299The murder of UnitedHealthcare's CEO put a violent point on the frustration and rage some Americans feel toward health insurance companies. But insurers are just one piece of America’s broken and expensive health care system.Guest:Aaron Carroll, CEO, Academy HealthLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.298. Presenting: First Opinion: Mark Cuban
34:00||Season 1, Ep. 298Businessman and entertainer Mark Cuban has long had an interest in health care, and a mission to disrupt the pharmaceutical industry.Torie Bosch, host of First Opinion, a podcast from STAT News, speaks with Cuban about one of his latest ventures Cost Plus Drugs - Mark’s efforts to drive down prescription drug prices. Guests:Torie Bosch, Editor, First Opinion, STAT NewsMatt Herper, Senior Writer, Medicine, STAT NewsMark Cuban, Co-Founder Cost Plus Drugs EntrepreneurLearn more and read a full transcript on here.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.297. Can the U.S. Put an End to Surprise Ambulance Bills?
32:40||Season 1, Ep. 297Congress banned most surprise medical bills back in 2020, with one major exception: ambulance rides. Most people agree that patients should be shielded from these unexpected charges. But who should pick up the tab instead? As state and federal policymakers grapple with that question, we delve into why finding a fair solution is harder than you’d think.Guests:Tara Bannow, Reporter, STATPrecious Mae Clark, patientDia Gainor, Executive Director, National Association of State EMS OfficialsZach Gaumer, Principal, Health Management AssociatesJames Gelfand, JD President and CEO, ERISA Industry CommitteeBob Herman, Reporter, STATPete Lawrence, Deputy Chief, Oceanside FireButch Oberhoff, President, Texas EMS AllianceLeslie Walker, Senior Reporter/Producer, TradeoffsMatt Zavadsky, At-Large Director, National Association of EMTsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.296. What Could RFK Jr. Do As Head of HHS? We Asked Someone Who’s Done the Job
23:17||Season 1, Ep. 296Former HHS Secretary Kathleen Sebelius shares what the country’s top health official can and can’t do, and what she wants senators to consider ahead of RFK’s confirmation hearings.Guest:Kathleen Sebelius, Former U.S. Secretary of Health and Human Services SecretaryLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.295. Health Care for Transgender Youth Goes to the Supreme Court
26:11||Season 1, Ep. 295Twenty-six states have passed bans on gender-affirming care for transgender minors, and the Supreme Court is set to hear arguments in December about Tennessee's ban. We take a closer look at gender-affirming care and the legal arguments that could influence how accessible that care is.Meredithe McNamara, MD, Assistant Professor of Pediatrics, Yale School of MedicineKatie Eyer, JD, Professor of Law, Rutgers Law SchoolJames Blumstein, LLB, University Distinguished Professor of Constitutional Law and Health Law & Policy, Vanderbilt University Law SchoolLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.294. How Did Picking a Medicare Plan Get So Hard?
24:36||Season 1, Ep. 294It’s Medicare open enrollment season, and in this episode first aired in 2021, we explain why shopping for a new plan is often tougher than it seems.Guests:Lilyan Grossman, Medicare beneficiaryTricia Neuman, ScD, Senior Vice President and Executive Director of the Program on Medicare Policy, Kaiser Family FoundationAmal Trivedi, MD, Professor of Medicine and Health Services, Policy, and Practice, Brown UniversityLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.293. What the Election Could Mean for Obamacare
17:19||Season 1, Ep. 293One of the nation’s leading experts on the Affordable Care Act breaks down its track record and weighs in on the stakes the historic health care law faces in the lead-up to the election.Guest:Larry Levitt, Executive Vice President for Health Policy, KFFLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.292. 3 Health Care Decisions Awaiting the Next President
26:27||Season 1, Ep. 292The next U.S. president will have to make consequential choices about the Affordable Care Act, prescription drug prices and abortion. We compare the positions of candidates Kamala Harris and Donald Trump on these major health policy issues. (NOTE: This episode has been updated to clarify the number of people who would lose health coverage if Affordable Care Act enhanced subsidies expired.)Guests:Michael Cannon, Director of Health Policy Studies, Cato InstituteEderlina Co, JD, Associate Professor of Law, University of the PacificCynthia Cox, Vice President and Director of Program on the ACA, KFFStacie Dusetzina, PhD, Professor of Health Policy, Vanderbilt University Medical CenterBenedic Ippolito, PhD, Senior Fellow, American Enterprise InstituteRyan Levi, Reporter/Producer, TradeoffsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.